Kronos Worldwide vs Luxfer
KRO and LXFR side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KRO and LXFR compare
Kronos Worldwide is the larger company, worth 1.9 times as much as Luxfer ($887M against $465M).
Kronos Worldwide grew revenue faster over the last twelve months (2.7% versus −11.8% for Luxfer).
Luxfer keeps more of each dollar of sales as profit, with a net margin of 1.7% compared with −5.6% at Kronos Worldwide.
Both pay dividends: Kronos Worldwide yields 2.6% and Luxfer 2.2%.
Luxfer scores higher on the StockData Score (11 against 4 for Kronos Worldwide), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KRO | LXFR |
|---|---|---|
| Size and price | ||
| Market cap | $887M | $465M |
| Share price | $7.71 | $17.36 |
| Change, 1 year | 63.0% | 43.8% |
| Change, 5 years | −46.6% | −12.4% |
| Beta (5Y) | 1.45 | 0.56 |
| Employees | 2,248 | 1,350 |
| StockData Score | ||
| Total score | 4 | 11 (better) |
| Valuation score | 2 (better) | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 1 | 2 (better) |
| Valuation | ||
| P/E | – | 75.5× |
| P/S | 0.5× (better) | 1.3× |
| P/B | 1.2× (better) | 2.1× |
| EV/EBITDA | – | 22.4× |
| P/FCF | – | 24.6× |
| FCF yield | – | 4.1% |
| Fair value | $11.40 | $8.47 |
| Margin of safety | 32.4% (better) | −105% |
| Growth | ||
| Revenue growth (TTM) | 2.7% (better) | −11.8% |
| Revenue growth, 5Y average | 2.6% | 3.4% (better) |
| Net income growth (TTM) | −262% | −56.6% (better) |
| EPS growth (TTM) | −261% | −56.6% (better) |
| EPS growth, 5Y average | – | −17.2% |
| Profitability | ||
| Gross margin | 11.8% | 25.1% (better) |
| Operating margin | −1.7% | 6.3% (better) |
| Net margin | −5.6% | 1.7% (better) |
| FCF margin | – | 5.3% |
| Return on equity | −13.7% | 2.7% (better) |
| Return on invested capital | −1.9% | 5.5% (better) |
| Financial health | ||
| Debt / equity | 0.76 | 0.26 (better) |
| Net debt / EBITDA | – | 1.69 |
| Interest coverage | −0.6× | 6.6× (better) |
| Current ratio | 3.30 (better) | 2.47 |
| Altman Z-score | 1.76 | 3.57 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.6% (better) | 2.2% |
| Payout ratio | – | 221% |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | −22.6% | – |
| Buyback yield | – | 0.56% |
| Shareholder yield | 2.6% | 2.8% (better) |
| Ownership | ||
| Held by institutions | 16.0% | 93.0% |
| Held by insiders | 0.21% | 2.0% |
| Insider net buying, 12 months | $98.5K (better) | −$322K |
| Short interest, % of float | 0.94% | 1.7% |
Go deeper
- KRO stock overview
- KRO income statement
- KRO valuation and score
- LXFR stock overview
- LXFR income statement
- LXFR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.